An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients

Mise à jour : Il y a 4 ans
Référence : NCT01615419

Femme et Homme

  • | Pays :
  • Greece
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This multi-center, observational study will evaluate the use in clinical practice and efficacy of RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra treatment according to the approved label will be followed for 6 months.


Critère d'inclusion

  • Rheumatoid Arthritis

Liens